1336 — New China Life Insurance Share Price
Last trade - 00:00- HK$46.04bn
- HK$45.24bn
- CNY44.07bn
- 27
- 96
- 20
- 44
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 3.52 | ||
| PEG Ratio (f) | 0.19 | ||
| EPS Growth (f) | 23.1% | ||
| Dividend Yield (f) | 9.03% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.41 | ||
| Price to Tang. Book | 0.42 | ||
| Price to Free Cashflow | 0.48 | ||
| Price to Sales | 0.97 | ||
| EV to EBITDA | 4.59 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.4% | ||
| Return on Equity | 8.58% | ||
| Operating Margin | 12.58% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 174,461 | 206,324 | 221,998 | 65,294 | 44,066 | 99,337.27 | 103,976.61 | -22.14% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +70.63 | +5.77 | +1.88 | +53.82 | -66.15 | +32.13 | +8.8 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
New China Life Insurance Company Ltd. is a China-based provider of life insurance services and products. The Company's main businesses consist of personal life insurance, group life insurance and wealth management business. The Company's personal life insurance products include traditional life insurance, participating life insurance, universal life insurance, investment-linked insurance, health insurance and casualty insurance. Its group insurance products include group life insurance, health insurance and casualty insurance. Through its subsidiaries, the Company is also engaged in insurance agent business. The Company distributes its insurance products primarily through insurance salesmen and banks.
Directors
- Zhibin Xu CHM (45)
- Quan Li PRE (57)
- Zheng Yang CFO (50)
- Xingfeng Gong VPR (51)
- Yuan Li VPR (58)
- Zhigang Yu VPR (56)
- Hong Zhang EDR (55)
- Sau Mei Ng SEC
- Aimin Hu NED (72)
- Qiqiang Li NED (50)
- Yulong Peng NED (42)
- Edouard Schmid NED (56)
- Xue Yang NED
- Yi Yang NED (48)
- Lie Cheng IND (64)
- Jianxin Geng IND (67)
- Xianglu Li IND (71)
- Yiu Tim Ma IND
- Wei Zheng IND (47)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 28th, 1996
- Public Since
- December 16th, 2011
- No. of Shareholders
- 85,492
- No. of Employees
- 30,662
- Sector
- Insurance
- Industry
- Financials
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 3,119,546,600
- Address
- New China Life Insurance Mansion, BEIJING, 100022
- Web
- https://www.newchinalife.com/
- Phone
- +86 1085213233
- Contact
- Xingfeng Gong
- Auditors
- Deloitte & Touche LLP
Upcoming Events for 1336
Similar to 1336
AIA
Stock Exchange of Hong Kong Limited
Asia Financial Holdings
Stock Exchange of Hong Kong Limited
China Life Insurance Co
Stock Exchange of Hong Kong Limited
China Reinsurance
Stock Exchange of Hong Kong Limited
China Taiping Insurance Holdings Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:15 UTC, shares in New China Life Insurance are trading at HK$14.76. This share price information is delayed by 15 minutes.
Shares in New China Life Insurance last closed at HK$14.76 and the price had moved by -32.91% over the past 365 days. In terms of relative price strength the New China Life Insurance share price has underperformed the FTSE Developed Asia Pacific Index by -32.85% over the past year.
The overall consensus recommendation for New China Life Insurance is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The New China Life Insurance dividend yield is 6.23% based on the trailing twelve month period.
Last year, New China Life Insurance paid a total dividend of CNY0.85, and it currently has a trailing dividend yield of 6.23%. We do not have any data on when New China Life Insurance is to next pay dividends.
We do not have data on when New China Life Insurance is to next pay dividends. The historic dividend yield on New China Life Insurance shares is currently 6.23%.
To buy shares in New China Life Insurance you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$14.76, shares in New China Life Insurance had a market capitalisation of HK$46.04bn.
Here are the trading details for New China Life Insurance:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1336
Based on an overall assessment of its quality, value and momentum New China Life Insurance is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in New China Life Insurance is HK$18.61. That is 26.08% above the last closing price of HK$14.76.
Analysts covering New China Life Insurance currently have a consensus Earnings Per Share (EPS) forecast of CNY3.77 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like New China Life Insurance. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -25.84%.
As of the last closing price of HK$14.76, shares in New China Life Insurance were trading -11.91% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The New China Life Insurance PE ratio based on its reported earnings over the past 12 months is 3.52. The shares last closed at HK$14.76.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
New China Life Insurance's management team is headed by:
- Zhibin Xu - CHM
- Quan Li - PRE
- Zheng Yang - CFO
- Xingfeng Gong - VPR
- Yuan Li - VPR
- Zhigang Yu - VPR
- Hong Zhang - EDR
- Sau Mei Ng - SEC
- Aimin Hu - NED
- Qiqiang Li - NED
- Yulong Peng - NED
- Edouard Schmid - NED
- Xue Yang - NED
- Yi Yang - NED
- Lie Cheng - IND
- Jianxin Geng - IND
- Xianglu Li - IND
- Yiu Tim Ma - IND
- Wei Zheng - IND